NCT00462189View on ClinicalTrials.gov

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Conditions
LeukemiaHairy Cell LeukemiaHCL
Interventions
DRUG

Immunotoxin therapy

DRUG

CAT-8015 Immunotoxin

PROCEDURE

Biological therapy

Trial Locations (5)

20892

RECRUITING

Warren Grant Megnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

60611

NOT_YET_RECRUITING

Cancer Center of Northwestern University, Chicago

94305

NOT_YET_RECRUITING

Stanford University School of Medicine, Stanford

Unknown

NOT_YET_RECRUITING

Klinika Hamtologii Uniwersytetu Medycznego (Medical University of Lodz), Lodz

NOT_YET_RECRUITING

Royal Marsden Hospital and Institute of Cancer Research, Surrey

Sponsors
All Listed Sponsors
lead

Cambridge Antibody Technology

OTHER

NCT00462189 - Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease | Biotech Hunter | Biotech Hunter